Arijit Roy

Arijit Roy

Auto-generated profile, based on publicly available information

Arijit Roy

Department of Physiology and Pharmacology, Hotchkiss Brain Institute and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2017 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
DBDavid Burns
David Burns
ARArijit Roy
Arijit Roy
ELEric F. Lucking
Eric F. Lucking
FMFiona B Mcdonald
Fiona B Mcdonald
SGSam Gray
Sam Gray
KOKen D. O'Halloran
Ken D. O'Halloran

4 December 2020 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
NJNicholas Jendzjowsky
Nicholas Jendzjowsky
ARArijit Roy
Arijit Roy
MIMircea Iftinca
Mircea Iftinca
NBNicole O. Barioni
Nicole O. Barioni
MKMargaret M. Kelly
Margaret M. Kelly
RWRichard J.A. Wilson
Richard J.A. Wilson
Key points: We have previously shown that carotid body stimulation by lysophosphatidic acid elicits a reflex stimulation of vagal efferent activity sufficient to cause bronchoconstriction in asthmatic rats. Here, we show that pathophysiological concentrations of asthma‐associated prototypical Th2 cytokines also stimulate the carotid bodies. Stimulation of the carotid bodies by these asthmakines involves a PKCε–transient receptor potential vanilloid 1 (TRPV1) signalling mechanism likely dependent on TRPV1 S502 and T704 phosphorylation sites. As the carotid bodies’ oxygen sensitivity is independent of PKCε–TRPV1 signalling, systemic blockade of PKCε may provide a novel therapeutic target to reduce allergen‐induced asthmatic bronchoconstriction. Consistent with the therapeutic potential of blocking the PKCε–TRPV1 pathway, systemic delivery of a PKCε‐blocking peptide suppresses asthmatic respiratory distress in response to allergen and reduces airway hyperresponsiveness to bradykinin. The autonomic nervous system orchestrates organ‐specific, systemic and behavioural responses to inflammation. Recently, we demonstrated a vital role for lysophosphatidic acid in stimulating the primary autonomic oxygen chemoreceptors, the carotid bodies, in parasympathetic‐mediated asthmatic airway hyperresponsiveness. However, the cacophony of stimulatory factors and cellular mechanisms of carotid body activation are unknown. Therefore, we set out to determine the intracellular signalling involved in carotid body‐mediated sensing of asthmatic blood‐borne inflammatory mediators. We employed a range of in vitro and rat in situ preparations, site‐directed mutagenesis, patch‐clamp, nerve recordings and pharmacological inhibition to assess cellular signalling. We show that the carotid bodies are also sensitive to asthma‐associated prototypical Th2 cytokines which elicit sensory nerve excitation. This provides additional asthmatic ligands contributing to the previously established reflex arc resulting in efferent vagal activity and asthmatic bronchoconstriction. This novel sensing role for the carotid body is mediated by a PKCε‐dependent stimulation of transient receptor potential vanilloid 1 (TRPV1), likely via TRPV1 phosphorylation at sites T704 and S502. Importantly, carotid body oxygen sensing was unaffected by blocking either PKCε or TRPV1. Further, we demonstrate that systemic PKCε blockade reduces asthmatic respiratory distress in response to allergen and airway hyperresponsiveness. These discoveries support an inflammation‐dependent, oxygen‐independent function for the carotid body and suggest that targeting PKCε provides a novel therapeutic option to abate allergic airway disease without altering life‐saving autonomic hypoxic reflexes.

4 January 2018 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
ARArijit Roy
Arijit Roy
MFMelissa Farnham
Melissa Farnham
FDFatemeh Derakhshan
Fatemeh Derakhshan
PPPaul M. Pilowsky
Paul M. Pilowsky
RWRichard J. A. Wilson
Richard J. A. Wilson

25 March 2022 in Science Advances
Verified
Journal Article
Open access
NBNicole O. Barioni
Nicole O. Barioni
FDFatemeh Derakhshan
Fatemeh Derakhshan
LLLuana Tenorio Lopes
Luana Tenorio Lopes
HOHiroshi Onimaru
Hiroshi Onimaru
ARArijit Roy
Arijit Roy
RWRichard J. A. Wilson
Richard J. A. Wilson
As blood oxygenation decreases (hypoxemia), mammals mount cardiorespiratory responses, increasing oxygen to vital organs. The carotid bodies are the primary oxygen chemoreceptors for breathing, but sympathetic-mediated cardiovascular responses to hypoxia persist in their absence, suggesting additional high-fidelity oxygen sensors. We show that spinal thoracic sympathetic preganglionic neurons are excited by hypoxia and silenced by hyperoxia, independent of surrounding astrocytes. These spinal oxygen sensors (SOS) enhance sympatho-respiratory activity induced by CNS asphyxia-like stimuli, suggesting they bestow a life-or-death advantage. Our data suggest the SOS use a mechanism involving neuronal nitric oxide synthase 1 (NOS1) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX). We propose NOS1 serves as an oxygen-dependent sink for NADPH in hyperoxia. In hypoxia, NADPH catabolism by NOS1 decreases, increasing availability of NADPH to NOX and launching reactive oxygen species–dependent processes, including transient receptor potential channel activation. Equipped with this mechanism, SOS are likely broadly important for physiological regulation in chronic disease, spinal cord injury, and cardiorespiratory crisis.

1 January 2002
Verified
Book Chapter
Closed access
PDF file
DWDavid F Wilson
David F Wilson
SES. M. Evans
S. M. Evans
CRC. Rozanov
C. Rozanov
ARA. Roy
A. Roy
CKC. J. Koch
C. J. Koch
SLS. Lahiri
S. Lahiri